Patents by Inventor Daniel G. Lawton

Daniel G. Lawton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDS
    Publication number: 20140121202
    Abstract: S-t-butyl protected cysteine di-peptide analogs and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of Central Nervous System (CNS).
    Type: Application
    Filed: January 6, 2014
    Publication date: May 1, 2014
    Applicant: Promentis Pharmaceuticals, Inc.
    Inventors: Edward M. Johnson, Daniel G. Lawton
  • S-t-butyl protected cysteine di-peptide analogs and related compounds
    Patent number: 8624052
    Abstract: S-t-butyl protected cysteine di-peptide analogs and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of Central Nervous System (CNS).
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: January 7, 2014
    Assignee: Promentis Pharmaceuticals, Inc.
    Inventors: Edward M. Johnson, Daniel G. Lawton
  • Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease
    Publication number: 20130338165
    Abstract: Methods of treating Parkinson's Disease comprising administering compounds that up-regulate cystine-glutamate exchange (system Xc?) and/or increase glutathione levels in the brain cells. Preferred compounds are cysteine/cystine prodrugs or N-acetyl cysteine (NAC) prodrugs.
    Type: Application
    Filed: June 17, 2013
    Publication date: December 19, 2013
    Inventors: David A. Baker, Daniel G. Lawton, Chad Beyer, Michael Neary
  • S-Protected Cysteine Analogs and Related Compounds
    Publication number: 20120122793
    Abstract: S-protected cysteine analogs and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of Central Nervous System (CNS).
    Type: Application
    Filed: November 11, 2011
    Publication date: May 17, 2012
    Applicant: PROMENTIS PHARMACEUTICALS, INC.
    Inventors: Edward M. Johnson, Daniel G. Lawton
  • S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDS
    Publication number: 20120122792
    Abstract: S-t-butyl protected cysteine di-peptide analogs and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of Central Nervous System (CNS).
    Type: Application
    Filed: November 11, 2011
    Publication date: May 17, 2012
    Applicant: PROMENTIS PHARMACEUTICALS, INC.
    Inventors: Edward M. Johnson, II, Daniel G. Lawton